| |
| |
|
| Insider
Information: |
Zaderej Karen L. |
| Relationship: |
|
| City: |
Alachua |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,208,135 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,812,976 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,208,135 |
|
|
| Total
Value |
$7,812,976 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -18.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axogen Inc |
AXGN |
CEO, Director |
2024-03-21 |
1,143,788 |
|
0 |
Premium* |
|
|
Vive Medical Inc |
VIVE |
Director |
2019-07-01 |
62,347 |
2018-10-01 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2023-07-11 |
2,000 |
2023-07-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXGN |
Axogen Inc |
President and CEOOfficer |
• • – |
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,049 |
|
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2012-11-20 |
4 |
B |
$2.69 |
$269 |
D/D |
100 |
119,890 |
2.73 |
- |
|
| VIVE |
Vive Medical Inc |
Director |
• • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
746 |
746 |
0 |
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2012-12-10 |
4 |
B |
$2.50 |
$2,250 |
D/D |
900 |
120,790 |
2.73 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2021-12-20 |
4 |
D |
$9.24 |
$11,485 |
D/D |
(1,243) |
923,029 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2020-12-21 |
4 |
S |
$16.42 |
$20,936 |
D/D |
(1,275) |
646,719 |
0 |
% |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2014-03-13 |
4 |
B |
$3.47 |
$5,233 |
D/D |
1,500 |
136,874 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2021-12-27 |
4 |
D |
$9.74 |
$17,064 |
D/D |
(1,752) |
925,677 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2023-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
647,994 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2021-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
924,272 |
0 |
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2015-05-27 |
4 |
B |
$3.10 |
$10,493 |
D/D |
3,325 |
232,147 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2020-12-29 |
4 |
S |
$17.81 |
$62,335 |
D/D |
(3,500) |
674,099 |
0 |
% |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2021-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,400 |
927,429 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,400 |
1,012,695 |
0 |
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2014-05-12 |
4 |
B |
$2.70 |
$13,500 |
D/D |
5,000 |
329,056 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2014-06-03 |
4 |
B |
$2.43 |
$12,150 |
D/D |
5,000 |
334,056 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2020-02-18 |
4 |
D |
$14.68 |
$79,698 |
D/D |
(5,429) |
631,229 |
0 |
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
135,374 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2019-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
599,530 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2018-11-19 |
4 |
D |
$28.37 |
$191,810 |
D/D |
(6,761) |
446,209 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2021-02-17 |
4 |
D |
$18.71 |
$143,805 |
D/D |
(7,686) |
631,412 |
0 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2021-08-12 |
4 |
OE |
$5.09 |
$42,013 |
D/D |
8,254 |
822,272 |
0 |
- |
|
| AXGN |
Axogen Inc |
Chief Executive Officer |
• • – |
2013-08-14 |
4 |
B |
$3.00 |
$25,002 |
D/D |
8,334 |
129,124 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CEO |
• • – |
2020-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,800 |
677,599 |
0 |
- |
|
64 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
